Sanghuangporus vaninii Polysaccharide Hydrogel Attenuates DNFB ‐Induced Atopic Dermatitis in Mice via Immunomodulation
The FASEB Journal · 15.11.2026 · 40 (21)
DOI: 10.1096/fj.202601990r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 02.11.2026. Verfasst von Wei Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural Universi…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Dinitrofluorobenzene, Hydrogels, Basidiomycota. Die Arbeit nennt 53 Literaturangaben. Gefördert von: | Jilin Provincial Scientific and Technological Development Program (Jilin Scientific and Technological Development Program), Jilin Provincial Scientific and Technological Development Program.
Abstract (Originalsprache)
Atopic dermatitis (AD), a prevalent chronic inflammatory skin disorder, highlights the need for advanced immunomodulatory therapies. We isolated three novel polysaccharides (SVP1–SVP3) from Sanghuangporus vaninii , characterized their physicochemical properties, and formulated them into hydrogels. These were applied to 2,4‐dinitrofluorobenzene (DNFB)‐induced AD mouse models to investigate their therapeutic effects and underlying mechanisms. SVP hydrogels, notably SVP3, significantly attenuated AD pathology including scratching frequency, dermatitis severity, epidermal hyperplasia, and mast cell infiltration compared to the blank hydrogel control. Crucially, SVP3 alleviated immune dysregulation by lowering CD4 + T cells and increasing CD8 + T cells, suppressing the secretion of both Th1 and Th2 signature cytokines, and remodeling the disordered inflammatory cytokine network. Mechanistic analysis indicated suppressed activation of the TLR4/MyD88/NF‐κB pathway accompanied by decreased protein expression, alongside inhibited nuclear translocation of p‐NF‐κB p65 and p‐STAT3. Our findings suggest that SVP3 alleviates AD symptoms partly through modulation of TLR4/MyD88/NF‐κB signaling, supporting its value as a promising therapeutic strategy for immunomodulation in inflammatory skin disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, Changchun, China.
- College of Food Science and Pharmaceutical Engineering, Zaozhuang University, Zaozhuang, China.
- Jilin Provincial International Joint Research Center for the Development and Utilization of Authentic Medicinal Materials, College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
- JiLin Ferry Innovation Factory Group, Changchun, China.
ORCID-Profile: Lu Fu
Förderung
- | Jilin Provincial Scientific and Technological Development Program (Jilin Scientific and Technological Development Program)
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Li, W., Guo, C., Jin, Y., Wang, W., Ji, H., Zhang, L., Zhang, W., Li, W., & Fu, L. (2026). Sanghuangporus vaninii Polysaccharide Hydrogel Attenuates DNFB ‐Induced Atopic Dermatitis in Mice via Immunomodulation. The FASEB Journal, 40(21). https://doi.org/10.1096/fj.202601990r
Vancouver
Li W, Guo C, Jin Y, Wang W, Ji H, Zhang L, et al. Sanghuangporus vaninii Polysaccharide Hydrogel Attenuates DNFB ‐Induced Atopic Dermatitis in Mice via Immunomodulation. The FASEB Journal. 2026;40(21). doi:10.1096/fj.202601990r
BibTeX
@article{Li2026,
author = {Li, Wei and Guo, Chunhe and Jin, Yudi and Wang, Wenzhe and Ji, Hong and Zhang, Linbo and Zhang, Wenhui and Li, Wei and Fu, Lu},
title = {Sanghuangporus vaninii Polysaccharide Hydrogel Attenuates DNFB ‐Induced Atopic Dermatitis in Mice via Immunomodulation},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {21},
doi = {10.1096/fj.202601990r}
}
EUVIMED